Bio-Gate AG Statistics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 3.96 million. The enterprise value is 6.48 million.
Important Dates
The next estimated earnings date is Thursday, December 10, 2026.
| Earnings Date | Dec 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio-Gate AG has 2.04 million shares outstanding. The number of shares has increased by 10.28% in one year.
| Current Share Class | 2.04M |
| Shares Outstanding | 2.04M |
| Shares Change (YoY) | +10.28% |
| Shares Change (QoQ) | -8.53% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | 7.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 4.15.
| Current Ratio | 2.16 |
| Quick Ratio | 0.46 |
| Debt / Equity | 4.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.45 |
Financial Efficiency
Return on equity (ROE) is -174.61% and return on invested capital (ROIC) is -33.73%.
| Return on Equity (ROE) | -174.61% |
| Return on Assets (ROA) | -18.67% |
| Return on Invested Capital (ROIC) | -33.73% |
| Return on Capital Employed (ROCE) | -40.26% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | 141,508 |
| Profits Per Employee | -27,437 |
| Employee Count | 48 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.80% in the last 52 weeks. The beta is 0.12, so Bio-Gate AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -51.80% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 20.16 |
| Average Volume (20 Days) | 54 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Gate AG had revenue of EUR 6.79 million and -1.32 million in losses. Loss per share was -0.65.
| Revenue | 6.79M |
| Gross Profit | 3.77M |
| Operating Income | -1.21M |
| Pretax Income | -1.33M |
| Net Income | -1.32M |
| EBITDA | -982,791 |
| EBIT | -1.21M |
| Loss Per Share | -0.65 |
Full Income Statement Balance Sheet
The company has 78,418 in cash and 2.54 million in debt, with a net cash position of -2.46 million or -1.21 per share.
| Cash & Cash Equivalents | 78,418 |
| Total Debt | 2.54M |
| Net Cash | -2.46M |
| Net Cash Per Share | -1.21 |
| Equity (Book Value) | 612,014 |
| Book Value Per Share | 0.27 |
| Working Capital | 1.08M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -1.06 million and capital expenditures -3,000, giving a free cash flow of -1.06 million.
| Operating Cash Flow | -1.06M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 232,000 |
| Net Borrowing | 410,000 |
| Free Cash Flow | -1.06M |
| FCF Per Share | -0.52 |
Full Cash Flow Statement Margins
Gross margin is 55.43%, with operating and profit margins of -17.88% and -19.39%.
| Gross Margin | 55.43% |
| Operating Margin | -17.88% |
| Pretax Margin | -19.65% |
| Profit Margin | -19.39% |
| EBITDA Margin | -14.47% |
| EBIT Margin | -17.88% |
| FCF Margin | n/a |
Dividends & Yields
Bio-Gate AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.28% |
| Shareholder Yield | -10.28% |
| Earnings Yield | -33.30% |
| FCF Yield | -26.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Bio-Gate AG is 8.76, which is 351.44% higher than the current price. The consensus rating is "Buy".
| Price Target | 8.76 |
| Price Target Difference | 351.44% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 2.98% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 28, 2026. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jul 28, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
Bio-Gate AG has an Altman Z-Score of -3.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.18 |
| Piotroski F-Score | 3 |